Cencora, Inc.

Cencora is a leading global pharmaceutical solutions organization headquartered in Conshohocken, Pennsylvania, U.S.. Its mission is to create healthier futures by responsibly connecting medicines, manufacturers, and caregivers to improve patient outcomes. The company, formerly known as AmerisourceBergen Corporation, rebranded to Cencora in 2023, building on a legacy of over 100 years in pharmaceutical sourcing and wholesale distribution.

Cencora's core business encompasses pharmaceutical distribution, specialty patient services, temperature-controlled global logistics, and manufacturer commercialization support. It distributes a wide range of products, including brand-name and generic pharmaceuticals, over-the-counter healthcare products, and home healthcare supplies and equipment. The company serves diverse healthcare providers such as hospitals, health systems, independent and chain retail pharmacies, physician practices, and also operates in the animal health market.

In October 2024, Robert P. Mauch assumed the role of President and Chief Executive Officer, succeeding Steven H. Collis. Cencora is a significant player in the pharmaceutical industry, distributing approximately 20% of all pharmaceuticals in the United States and operating in over 50 countries globally. Recent notable activities include strategic acquisitions, such as expanding Retina Consultants of America through the acquisition of EyeSouth Partners' Retina Business, and various senior notes offerings.